CytomX Therapeutics

CytomX Therapeutics

Biotechnology

South San Francisco, CA 11,176 followers

Transforming lives with safer, more effective therapies

About us

CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected. We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population. CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category. CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at www.cytomX.com.

Industry
Biotechnology
Company size
51-200 employees
Headquarters
South San Francisco, CA
Type
Public Company

Locations

  • Primary

    151 Oyster Point Blvd

    South San Francisco, CA 94080, US

    Get directions

Employees at CytomX Therapeutics

Updates

Similar pages

Browse jobs

Funding

CytomX Therapeutics 8 total rounds

Last Round

Post IPO equity

US$ 93.6M

See more info on crunchbase